HK1006570A1 - 1,7-fused 1h-indole-2-carboxylic n-(1,4-benzodiazepin-3-yl)-amides - Google Patents

1,7-fused 1h-indole-2-carboxylic n-(1,4-benzodiazepin-3-yl)-amides

Info

Publication number
HK1006570A1
HK1006570A1 HK98105568A HK98105568A HK1006570A1 HK 1006570 A1 HK1006570 A1 HK 1006570A1 HK 98105568 A HK98105568 A HK 98105568A HK 98105568 A HK98105568 A HK 98105568A HK 1006570 A1 HK1006570 A1 HK 1006570A1
Authority
HK
Hong Kong
Prior art keywords
lower alkyl
represents hydrogen
halogen
carbon atoms
fused
Prior art date
Application number
HK98105568A
Other languages
English (en)
Inventor
Peter-Colin Gregory
Derk Hamminga
Ineke Van Wijngaarden
Klaus-Ullrich Wolf
Harald Waldeck
Werner Benson
Horst Zeugner
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE3907390A external-priority patent/DE3907390A1/de
Priority claimed from DE3907389A external-priority patent/DE3907389A1/de
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Publication of HK1006570A1 publication Critical patent/HK1006570A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/06—Peri-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Indole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
HK98105568A 1989-03-08 1998-06-17 1,7-fused 1h-indole-2-carboxylic n-(1,4-benzodiazepin-3-yl)-amides HK1006570A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3907390A DE3907390A1 (de) 1989-03-08 1989-03-08 Neue 1,7-anellierte 1h-indol-2-carbonsaeure-n-(5-phenyl-1,4-benzodiazepin-3-yl)amide
DE3907389A DE3907389A1 (de) 1989-03-08 1989-03-08 Neue 1,7-anellierte 1h-indol-carbonsaeure-n-(5-alkyl-1,4-benzodiazepin-3-yl)amide

Publications (1)

Publication Number Publication Date
HK1006570A1 true HK1006570A1 (en) 1999-03-05

Family

ID=25878542

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98105568A HK1006570A1 (en) 1989-03-08 1998-06-17 1,7-fused 1h-indole-2-carboxylic n-(1,4-benzodiazepin-3-yl)-amides

Country Status (20)

Country Link
US (1) US5010076A (no)
EP (1) EP0387618B1 (no)
JP (1) JP3010558B2 (no)
KR (1) KR920003627B1 (no)
CN (1) CN1032208C (no)
AT (1) ATE109146T1 (no)
AU (1) AU616835B2 (no)
CS (1) CS390091A3 (no)
DE (1) DE59006544D1 (no)
DK (1) DK0387618T3 (no)
ES (1) ES2057216T3 (no)
FI (1) FI92486C (no)
HK (1) HK1006570A1 (no)
HU (2) HU207317B (no)
IE (1) IE65030B1 (no)
IL (1) IL93401A (no)
NO (1) NO173869C (no)
NZ (1) NZ232774A (no)
PH (1) PH26955A (no)
PT (1) PT93360B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07103105B2 (ja) * 1989-05-12 1995-11-08 杏林製薬株式会社 インドール誘導体及びその製造方法
US5264419A (en) * 1990-08-31 1993-11-23 Warner-Lambert Company N-substituted cycloalkyl and polycycloalkyl α-substituted TRP derivatives
CA2068355A1 (en) * 1991-05-14 1992-11-15 Mark S. Chambers Benzodiazephine derivatives, compositions containing them and their use in therapy
DE4128015A1 (de) * 1991-08-23 1993-02-25 Kali Chemie Pharma Gmbh 1,7-anellierte 2-(piperazinoalkyl)indol-derivate sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindugnen enthaltende arzneimittel
GB9203790D0 (en) * 1992-02-21 1992-04-08 Merck Sharp & Dohme Therapeutic agents
US5360802A (en) * 1992-05-11 1994-11-01 Merck Sharpe & Dohme Ltd. Benzodiazepine derivatives, compositions containing them and their use in therapy
DE4304806A1 (de) * 1993-02-17 1994-08-18 Kali Chemie Pharma Gmbh 5-Phenyl-pyrrolo-1,4-benzoxazin- und -thiazin-Derivate sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US5556969A (en) * 1994-12-07 1996-09-17 Merck Sharp & Dohme Ltd. Benzodiazepine derivatives
NZ314105A (en) * 1996-02-02 1997-12-19 Sumitomo Pharma Guanidine derivative substituted with a substituted indole which is peri condensed with a heterocyclic ring
EP1891954A3 (en) * 1998-09-30 2009-01-14 Takeda Pharmaceutical Company Limited Acetylcholinesterase inhibitors for improving excretory potency of urinary bladder
WO2002098865A2 (fr) * 2001-06-07 2002-12-12 Neuro3D Inhibiteurs des phosphodiesterases des nucleotides cycliques, preparation et utilisations de ces inhibiteurs
FR2846653B1 (fr) * 2002-10-30 2007-04-20 Neuro3D Inhibiteurs des phosphodiesterases des nucleotides cycliques, preparation et utilisations
AU2003288352A1 (en) * 2002-10-30 2004-06-07 Centre National De La Recherche Scientifique (Cnrs) Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses
WO2014098000A1 (en) * 2012-12-17 2014-06-26 Daiichi Sankyo Company, Limited Process for preparation of a tricyclic heterocycle

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3471308D1 (en) * 1983-10-17 1988-06-23 Synthelabo Imidazoline derivatives, their preparation and therapeutical use
US4820834A (en) * 1984-06-26 1989-04-11 Merck & Co., Inc. Benzodiazepine analogs
CA1332410C (en) * 1984-06-26 1994-10-11 Roger M. Freidinger Benzodiazepine analogs
FR2567126B1 (fr) * 1984-07-06 1986-12-12 Synthelabo Derives de pyrrolo(1,2,3-de) benzoxazine et benzothiazine, leur preparation et leur application en therapeutique
US4628084A (en) * 1986-01-02 1986-12-09 Merck & Co., Inc. Process for 3-acylamino benzodiazepines
ZA889166B (en) * 1987-12-10 1990-05-30 Duphar Int Res 1,7-annelated indolecarboxylic acid esters and -amides
FR2630440B1 (fr) * 1988-04-25 1991-09-20 Jouveinal Sa Benzodiazepines, leur procede et intermediaires de preparation et leurs applications en therapeutique
IL91361A (en) * 1988-09-09 1994-10-07 Fujisawa Pharmaceutical Co Benzodiazepinone compounds [4,1] connected via positions 1 and 9 and carrying two transducers, processes for their preparation and pharmaceutical preparations containing them
FR2652352A1 (fr) * 1989-09-28 1991-03-29 Jouveinal Sa Benzodiazepines, leur procede et intermediaires de preparation et leurs applications en therapeutique.

Also Published As

Publication number Publication date
ES2057216T3 (es) 1994-10-16
NO901083D0 (no) 1990-03-07
IL93401A (en) 1994-08-26
US5010076A (en) 1991-04-23
DK0387618T3 (da) 1994-08-22
IE65030B1 (en) 1995-10-04
AU616835B2 (en) 1991-11-07
EP0387618A1 (de) 1990-09-19
PH26955A (en) 1992-12-03
ATE109146T1 (de) 1994-08-15
NO901083L (no) 1990-09-10
HU210354A9 (en) 1995-03-28
IE900813L (en) 1990-09-08
FI901154A0 (fi) 1990-03-07
NO173869C (no) 1994-02-16
HU901333D0 (en) 1990-05-28
IL93401A0 (en) 1990-11-29
CN1032208C (zh) 1996-07-03
JP3010558B2 (ja) 2000-02-21
PT93360B (pt) 1996-02-29
KR900014391A (ko) 1990-10-23
EP0387618B1 (de) 1994-07-27
JPH02273678A (ja) 1990-11-08
HU207317B (en) 1993-03-29
KR920003627B1 (ko) 1992-05-04
FI92486C (fi) 1994-11-25
AU5075390A (en) 1990-09-13
CS390091A3 (en) 1992-06-17
NO173869B (no) 1993-11-08
DE59006544D1 (de) 1994-09-01
NZ232774A (en) 1991-04-26
PT93360A (pt) 1990-11-07
FI92486B (fi) 1994-08-15
CN1045392A (zh) 1990-09-19
HUT53641A (en) 1990-11-28

Similar Documents

Publication Publication Date Title
HK1006570A1 (en) 1,7-fused 1h-indole-2-carboxylic n-(1,4-benzodiazepin-3-yl)-amides
SE8505715D0 (sv) Indolderivat
ES555007A0 (es) Procedimiento para preparar compuestos de 5-alquil-1-fenil-2-piperazinoalquilpirazolin-3-ona.
ES533378A0 (es) Procedimiento para la preparacion de derivados de b-carbolinas.
PT97479A (pt) Processo de preparacao de {i}benzotieno{2,3(1h,4h)-dionas e de composicoes farmaceuticas que as contem
ZA854422B (en) 3-aminocarbonylmethoxy-5-phenylpyrazole compounds,method for their preparation and pharmaceutical compositions containing these compounds
CA2011658A1 (en) New 1,7-annelated 1h-indole-2-carboxylic acid-n-(1,4-benzodiazepin-3-yl) amides
PT92494A (pt) Processo para a preparacao de novos derivados do indol
PL246418A1 (en) Process for preparing n-/3-trifluoromethylphenyl/-n'-propargylpiperazine
GR76499B (no)
ATE53839T1 (de) 2,3-dihydro-3-phenyl-benzofuran-2-onacetamidderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
GB2039908A (en) N-substituted-6-oxamorphinans

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)